查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1641728

全球细胞遗传学市场按产品、技术、应用和最终用户划分 - 机会分析和产业预测（2024-2035 年）

Cytogenetics Market By Product, By Technique, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2024-2035
出版日期: | 出版商: Allied Market Research | 英文 322 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计 2023 年细胞遗传学市场价值为 28.094 亿美元，到 2035 年将达到 106.2705 亿美元，2024 年至 2035 年的复合年增长率为 11.7%。

细胞遗传学市场-IMG1

细胞遗传学是遗传学的一个分支，主要研究染色体，即细胞内含有 DNA 的结构。分析染色体的数量、结构和行为，以了解它们在遗传、疾病和生物功能中的作用。细胞遗传学技术，例如核型分析、萤光原位杂合反应(FISH) 和比较基因组杂合反应(CGH) 可以识别染色体异常，例如缺失、重复、易位和非整倍体。这些异常与多种遗传性疾病、癌症和先天性疾病有关。透过检查细胞的染色体组成，细胞遗传学在产前检测、癌症研究、遗传咨询和个人化医疗中发挥重要作用。这个领域连结了传统遗传学和现代分子生物学，深入了解染色体层面的变化如何影响个人健康和研究，加速临床和研究的进步。

推动细胞遗传学市场成长的主要因素是全球遗传疾病和癌症的发生率不断上升，从而刺激了对细胞遗传学检测和诊断的需求。随着唐氏症等遗传性疾病和各种癌症变得越来越普遍，对准确、早期检测方法的需求也显着增加。细胞遗传学技术，例如核型分析、萤光原位杂合反应(FISH) 和染色体微阵列分析(CMA)，对于识别与这些疾病相关的染色体异常至关重要，从而推动市场成长。 。

然而，细胞遗传学技术高成本，包括设备和专业知识，可能令人望而却步，尤其是在低收入和中等收入国家，这限制了人们获得先进诊断工具的机会。此外，细胞遗传学程序的复杂性需要熟练的专业人员和专门的培训，而某些地区却供不应求，进一步限制了市场的成长。另一方面，个人化医疗的需求不断增长，这在很大程度上依赖先进的基因检测来根据个别患者的基因特征制定治疗方案，而新兴国家的高成长潜力正在为市场扩张创造机会。

细胞遗传学市场分为产品、技术、应用、最终用户和地区。根据产品类型，该部门分为消耗品、设备、软体和服务。消耗品部分进一步分为检测套组和试剂、培养基、探针等。培养基部分也包括血清培养基等。根据技术，市场分为比较杂合反应、萤光原位杂合反应、核型分析和其他。核型分析又分为产前检测、癌症和其他。产前检测部分分为消耗品、设备、软体和服务。肿瘤学领域进一步分为消耗品，包括检测套组、试剂和培养基。其余归类为消耗品，包括检测套组、试剂和培养基。

依应用分为遗传疾病、癌症、个人化医疗和其他。根据最终用户，市场分为临床/研究机构、製药/生技公司、学术研究机构等。依地区划分，市场分为北美（美国、加拿大、墨西哥）、欧洲（德国、法国、英国、义大利、西班牙等）、亚太地区（日本、中国、印度、澳洲、韩国等） )、拉丁美洲和中东- 调查将在非洲（巴西、南非、沙乌地阿拉伯等）进行。

相关人员的主要利益

  • 该报告对 2023 年至 2035 年细胞遗传学市场分析的市场细分、当前趋势、估计、趋势和动态进行了定量分析，并确定了细胞遗传学市场中的突出机会。
  • 它为市场研究提供与市场驱动因素、市场限制因素和市场机会相关的资讯。
  • 波特五力分析强调了买家和供应商的潜力，帮助相关人员做出利润驱动的商业决策，并加强供应商-买家网络。
  • 对细胞遗传学市场细分的详细分析有助于确定市场机会。
  • 每个地区的主要国家都根据收益贡献进行划分。
  • 市场公司的定位有利于基准化分析，并能清楚了解市场公司的当前地位。
  • 报告包括对区域和全球细胞遗传学市场趋势、主要企业、细分市场、应用领域和市场成长策略的分析。

本报告中提供的自订功能

  • 监管指南
  • 根据客户兴趣加入公司简介
  • 扩展公司简介列表
  • 历史市场资料

目录

第 1 章 简介

第 2 章执行摘要

第三章 市场概况

  • 市场定义和范围
  • 主要发现
    • 影响因素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 驱动程式
      • 遗传疾病盛行率不断上升
      • 提高对个人化医疗的认识与采用
      • 技术进步
    • 限制因素
      • 设备和程序成本高昂
    • 机会
      • 更加重视研发
      • 新兴国家高成长潜力

第四章 细胞遗传学市场（按产品）

  • 概述
  • 耗材
  • 装置
  • 软体和服务

5. 细胞遗传学市场（依技术划分）

  • 概述
  • 比较杂合反应
  • 萤光原位杂合反应
  • 核型分析
  • 其他的

第六章 细胞遗传学市场（按应用）

  • 概述
  • 遗传性疾病
  • 癌症
  • 个人化医疗
  • 其他的

7. 细胞遗传学市场（依最终用户划分）

  • 概述
  • 临床研究所
  • 製药和生物技术公司
  • 学术研究所
  • 其他的

8. 细胞遗传学市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲、中东和非洲
    • 巴西
    • 南非
    • 沙乌地阿拉伯
    • 其他的

第九章 竞争格局

  • 介绍
  • 关键成功策略
  • 前 10 家公司的产品映射
  • 竞争仪錶板
  • 竞争热图
  • 主要企业定位（2023年）

第十章 公司简介

  • PAN-Biotech
  • Precipio, Inc.
  • Applied Spectral Imaging
  • Capricorn Scientific
  • Thermo Fisher Scientific Inc.
  • AddLife
简介目录
Product Code: A01786

The cytogenetics market was valued at $2,809.40 million in 2023 and is estimated to reach $10,627.05 million by 2035, exhibiting a CAGR of 11.7% from 2024 to 2035.

Cytogenetics Market - IMG1

Cytogenetics is a branch of genetics focused on the study of chromosomes, the structures within cells that contain DNA. It involves analyzing the number, structure, and behavior of chromosomes to understand their role in heredity, disease, and biological function. Techniques in cytogenetics, such as karyotyping, fluorescence in situ hybridization (FISH), and comparative genomic hybridization (CGH), allow scientists to identify chromosomal abnormalities, such as deletions, duplications, translocations, and aneuploidies. These abnormalities are linked to various genetic disorders, cancers, and congenital conditions. By examining the chromosomal makeup of cells, cytogenetics plays a crucial role in prenatal diagnosis, cancer research, genetic counseling, and personalized medicine. The field bridges classical genetics with modern molecular biology, offering insights into how changes at the chromosomal level can affect an individual's health and development, making it an essential tool in both clinical and research settings.

The major factors that drive the growth of cytogenetics market include the rise in prevalence of genetic disorders and cancer globally which fuels demand for cytogenetic testing and diagnostics. As genetic conditions such as Down syndrome, and various types of cancer become more prevalent, the need for accurate and early detection methods has grown significantly. Cytogenetic techniques, including karyotyping, fluorescence in situ hybridization (FISH), and chromosomal microarray analysis (CMA), are essential for identifying chromosomal abnormalities associated with these conditions, thereby driving market growth.

However, the high cost associated with cytogenetic technologies, including equipment, and specialized expertise can be prohibitive, particularly in low- and middle-income countries, limiting access to advanced diagnostic tools and limiting the market growth. In addition, the complexity of cytogenetic procedures requires skilled professionals and specialized training, which can be scarce in certain regions, further constraining market growth. On the other hand, increase in demand for personalized medicine, which relies heavily on advanced genetic testing to tailor treatments to individual patients' genetic profiles and high growth potential in emerging countries create an opportunity for market expansion.

Cytogenetics market is categorized into product, technique, application, end user, and region. On the basis of the product, it is segmented into consumable, instrument, and software & service. The consumables segment is further classified into testing kits and reagents, media, probes, and others. Media segment further includes serum media and others. On the basis of technique, the market is segmented into comparative genome hybridization, fluorescence in situ hybridization, karyotyping, and others. The karyotyping segment further categorized into prenatal testing, cancer, and others. Prenatal testing segment categorized into consumable, instrument, and software & services. Cancer segment further categorized into consumables which includes testing kits and reagents and media. Others segment also categorized into consumables which includes testing kits and reagents and media.

On the basis of application, it is segmented into genetic disorders, cancer, personalized medicine, and others. On the basis of end user, the market is classified into clinical and research laboratory, pharmaceutical and biotechnology company, academic research institute, and others. Region-wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, Rest of LAMEA).

The major companies profiled in the report include PAN-Biotech, Precipio, Inc., Applied Spectral Imaging, Capricorn Scientific, AddLife, and Thermo Fisher Scientific Inc. The key players operating in the market have adopted partnership, joint venture, collaboration, and agreement as their key strategy to expand their product portfolio. For instance, in January 2024, Barco and Applied Spectral Imaging (ASI), a world leader in advanced biomedical imaging with a comprehensive product portfolio for karyotyping, H&E, IHC and FISH imaging and analysis, announced a new commercial partnership to offer best-in-class digital solutions for pathology laboratories

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cytogenetics market analysis from 2023 to 2035 to identify the prevailing cytogenetics market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the cytogenetics market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global cytogenetics market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Product

  • Consumable
    • Type
    • Testing kits
    • Media

◦ Type

    • Probes
    • Others
  • Instrument
  • Software and service

By Technique

  • Comparitive genome hybridization
  • Fluorescence in situ hybridization
  • Karyotyping
    • Type
    • Prenatal Testing

◦ Type

    • Cancer

◦ Consumables

    • Others

◦ Consumable

  • Others

By Application

  • Genetic disorder
  • Cancer
  • Personalized medicine
  • Others

By End User

  • Clinical and research laboratory
    • Type
    • Cancer Research
    • Clinical Diagnostics Labs
    • Others
  • Pharmaceutical and biotechnology company
  • Academic Research Institute
  • Other

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa,
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • AddLife
    • Applied Spectral Imaging
    • PAN-Biotech
    • Precipio, Inc.
    • Capricorn Scientific
    • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in prevalence of genetic disorders
      • 3.4.1.2. Increase in awareness and adoption of personalized medicine
      • 3.4.1.3. Advancement in technology
    • 3.4.2. Restraints
      • 3.4.2.1. High costs of equipment and procedures
    • 3.4.3. Opportunities
      • 3.4.3.1. Increase in focus on R&D
      • 3.4.3.2. High growth potential in emerging countries

CHAPTER 4: CYTOGENETICS MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Consumable
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
    • 4.2.4. Consumable Cytogenetics Market by Type
      • 4.2.4.1. Media Cytogenetics Market by Type
  • 4.3. Instrument
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Software and service
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: CYTOGENETICS MARKET, BY TECHNIQUE

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Comparitive genome hybridization
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Fluorescence in situ hybridization
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Karyotyping
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
    • 5.4.4. Karyotyping Cytogenetics Market by Type
      • 5.4.4.1. Prenatal Testing Cytogenetics Market by Type
      • 5.4.4.1.1. Consumables Cytogenetics Market by Type
      • 5.4.4.2. Cancer Cytogenetics Market by Consumables
      • 5.4.4.2.1. Media Cytogenetics Market by Type
      • 5.4.4.3. Others Cytogenetics Market by Consumable
      • 5.4.4.3.1. Media Cytogenetics Market by Type
  • 5.5. Others
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: CYTOGENETICS MARKET, BY APPLICATION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Genetic disorder
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Cancer
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Personalized medicine
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country
  • 6.5. Others
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by region
    • 6.5.3. Market share analysis by country

CHAPTER 7: CYTOGENETICS MARKET, BY END USER

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Clinical and research laboratory
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
    • 7.2.4. Clinical and research laboratory Cytogenetics Market by Type
  • 7.3. Pharmaceutical and biotechnology company
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Academic Research Institute
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country
  • 7.5. Other
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by region
    • 7.5.3. Market share analysis by country

CHAPTER 8: CYTOGENETICS MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast By Region
  • 8.2. North America
    • 8.2.1. Key market trends, growth factors and opportunities
    • 8.2.2. Market size and forecast, by Product
    • 8.2.3. Market size and forecast, by Technique
    • 8.2.4. Market size and forecast, by Application
    • 8.2.5. Market size and forecast, by End User
    • 8.2.6. Market size and forecast, by country
      • 8.2.6.1. U.S.
      • 8.2.6.1.1. Market size and forecast, by Product
      • 8.2.6.1.2. Market size and forecast, by Technique
      • 8.2.6.1.3. Market size and forecast, by Application
      • 8.2.6.1.4. Market size and forecast, by End User
      • 8.2.6.2. Canada
      • 8.2.6.2.1. Market size and forecast, by Product
      • 8.2.6.2.2. Market size and forecast, by Technique
      • 8.2.6.2.3. Market size and forecast, by Application
      • 8.2.6.2.4. Market size and forecast, by End User
      • 8.2.6.3. Mexico
      • 8.2.6.3.1. Market size and forecast, by Product
      • 8.2.6.3.2. Market size and forecast, by Technique
      • 8.2.6.3.3. Market size and forecast, by Application
      • 8.2.6.3.4. Market size and forecast, by End User
  • 8.3. Europe
    • 8.3.1. Key market trends, growth factors and opportunities
    • 8.3.2. Market size and forecast, by Product
    • 8.3.3. Market size and forecast, by Technique
    • 8.3.4. Market size and forecast, by Application
    • 8.3.5. Market size and forecast, by End User
    • 8.3.6. Market size and forecast, by country
      • 8.3.6.1. Germany
      • 8.3.6.1.1. Market size and forecast, by Product
      • 8.3.6.1.2. Market size and forecast, by Technique
      • 8.3.6.1.3. Market size and forecast, by Application
      • 8.3.6.1.4. Market size and forecast, by End User
      • 8.3.6.2. France
      • 8.3.6.2.1. Market size and forecast, by Product
      • 8.3.6.2.2. Market size and forecast, by Technique
      • 8.3.6.2.3. Market size and forecast, by Application
      • 8.3.6.2.4. Market size and forecast, by End User
      • 8.3.6.3. UK
      • 8.3.6.3.1. Market size and forecast, by Product
      • 8.3.6.3.2. Market size and forecast, by Technique
      • 8.3.6.3.3. Market size and forecast, by Application
      • 8.3.6.3.4. Market size and forecast, by End User
      • 8.3.6.4. Italy
      • 8.3.6.4.1. Market size and forecast, by Product
      • 8.3.6.4.2. Market size and forecast, by Technique
      • 8.3.6.4.3. Market size and forecast, by Application
      • 8.3.6.4.4. Market size and forecast, by End User
      • 8.3.6.5. Spain
      • 8.3.6.5.1. Market size and forecast, by Product
      • 8.3.6.5.2. Market size and forecast, by Technique
      • 8.3.6.5.3. Market size and forecast, by Application
      • 8.3.6.5.4. Market size and forecast, by End User
      • 8.3.6.6. Rest of Europe
      • 8.3.6.6.1. Market size and forecast, by Product
      • 8.3.6.6.2. Market size and forecast, by Technique
      • 8.3.6.6.3. Market size and forecast, by Application
      • 8.3.6.6.4. Market size and forecast, by End User
  • 8.4. Asia-Pacific
    • 8.4.1. Key market trends, growth factors and opportunities
    • 8.4.2. Market size and forecast, by Product
    • 8.4.3. Market size and forecast, by Technique
    • 8.4.4. Market size and forecast, by Application
    • 8.4.5. Market size and forecast, by End User
    • 8.4.6. Market size and forecast, by country
      • 8.4.6.1. Japan
      • 8.4.6.1.1. Market size and forecast, by Product
      • 8.4.6.1.2. Market size and forecast, by Technique
      • 8.4.6.1.3. Market size and forecast, by Application
      • 8.4.6.1.4. Market size and forecast, by End User
      • 8.4.6.2. China
      • 8.4.6.2.1. Market size and forecast, by Product
      • 8.4.6.2.2. Market size and forecast, by Technique
      • 8.4.6.2.3. Market size and forecast, by Application
      • 8.4.6.2.4. Market size and forecast, by End User
      • 8.4.6.3. India
      • 8.4.6.3.1. Market size and forecast, by Product
      • 8.4.6.3.2. Market size and forecast, by Technique
      • 8.4.6.3.3. Market size and forecast, by Application
      • 8.4.6.3.4. Market size and forecast, by End User
      • 8.4.6.4. Australia
      • 8.4.6.4.1. Market size and forecast, by Product
      • 8.4.6.4.2. Market size and forecast, by Technique
      • 8.4.6.4.3. Market size and forecast, by Application
      • 8.4.6.4.4. Market size and forecast, by End User
      • 8.4.6.5. South Korea
      • 8.4.6.5.1. Market size and forecast, by Product
      • 8.4.6.5.2. Market size and forecast, by Technique
      • 8.4.6.5.3. Market size and forecast, by Application
      • 8.4.6.5.4. Market size and forecast, by End User
      • 8.4.6.6. Rest of Asia-Pacific
      • 8.4.6.6.1. Market size and forecast, by Product
      • 8.4.6.6.2. Market size and forecast, by Technique
      • 8.4.6.6.3. Market size and forecast, by Application
      • 8.4.6.6.4. Market size and forecast, by End User
  • 8.5. LAMEA
    • 8.5.1. Key market trends, growth factors and opportunities
    • 8.5.2. Market size and forecast, by Product
    • 8.5.3. Market size and forecast, by Technique
    • 8.5.4. Market size and forecast, by Application
    • 8.5.5. Market size and forecast, by End User
    • 8.5.6. Market size and forecast, by country
      • 8.5.6.1. Brazil
      • 8.5.6.1.1. Market size and forecast, by Product
      • 8.5.6.1.2. Market size and forecast, by Technique
      • 8.5.6.1.3. Market size and forecast, by Application
      • 8.5.6.1.4. Market size and forecast, by End User
      • 8.5.6.2. South Africa,
      • 8.5.6.2.1. Market size and forecast, by Product
      • 8.5.6.2.2. Market size and forecast, by Technique
      • 8.5.6.2.3. Market size and forecast, by Application
      • 8.5.6.2.4. Market size and forecast, by End User
      • 8.5.6.3. Saudi Arabia
      • 8.5.6.3.1. Market size and forecast, by Product
      • 8.5.6.3.2. Market size and forecast, by Technique
      • 8.5.6.3.3. Market size and forecast, by Application
      • 8.5.6.3.4. Market size and forecast, by End User
      • 8.5.6.4. Rest of LAMEA
      • 8.5.6.4.1. Market size and forecast, by Product
      • 8.5.6.4.2. Market size and forecast, by Technique
      • 8.5.6.4.3. Market size and forecast, by Application
      • 8.5.6.4.4. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product mapping of top 10 player
  • 9.4. Competitive dashboard
  • 9.5. Competitive heatmap
  • 9.6. Top player positioning, 2023

CHAPTER 10: COMPANY PROFILES

  • 10.1. PAN-Biotech
    • 10.1.1. Company overview
    • 10.1.2. Key executives
    • 10.1.3. Company snapshot
    • 10.1.4. Operating business segments
    • 10.1.5. Product portfolio
  • 10.2. Precipio, Inc.
    • 10.2.1. Company overview
    • 10.2.2. Key executives
    • 10.2.3. Company snapshot
    • 10.2.4. Operating business segments
    • 10.2.5. Product portfolio
    • 10.2.6. Business performance
    • 10.2.7. Key strategic moves and developments
  • 10.3. Applied Spectral Imaging
    • 10.3.1. Company overview
    • 10.3.2. Key executives
    • 10.3.3. Company snapshot
    • 10.3.4. Operating business segments
    • 10.3.5. Product portfolio
    • 10.3.6. Key strategic moves and developments
  • 10.4. Capricorn Scientific
    • 10.4.1. Company overview
    • 10.4.2. Key executives
    • 10.4.3. Company snapshot
    • 10.4.4. Operating business segments
    • 10.4.5. Product portfolio
  • 10.5. Thermo Fisher Scientific Inc.
    • 10.5.1. Company overview
    • 10.5.2. Key executives
    • 10.5.3. Company snapshot
    • 10.5.4. Operating business segments
    • 10.5.5. Product portfolio
    • 10.5.6. Business performance
    • 10.5.7. Key strategic moves and developments
  • 10.6. AddLife
    • 10.6.1. Company overview
    • 10.6.2. Key executives
    • 10.6.3. Company snapshot
    • 10.6.4. Operating business segments
    • 10.6.5. Product portfolio
    • 10.6.6. Business performance